These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6586100)

  • 1. The third (C3) and the fourth (C4) components of complement: labile binding site and covalent bond formation.
    Janatova J
    Ann N Y Acad Sci; 1983; 421():218-34. PubMed ID: 6586100
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of complement components C3 and C4 by cadralazine and its active metabolite.
    Andersson M; Hanson A; Englund G; Dahlbäck B
    Eur J Clin Pharmacol; 1991; 40(3):261-5. PubMed ID: 2060562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autolytic fragmentation of complement components C3 and C4 and its relationship to covalent binding activity.
    Sim RB; Sim E
    Ann N Y Acad Sci; 1983; 421():259-76. PubMed ID: 6202197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The internal thioester and the covalent binding properties of the complement proteins C3 and C4.
    Law SK; Dodds AW
    Protein Sci; 1997 Feb; 6(2):263-74. PubMed ID: 9041627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of an amine-reactive, heat-labile acyl residue in the fourth component of human complement, C4.
    Ichihara C; Nagasawa S; Koyama J
    J Biochem; 1981 Aug; 90(2):423-32. PubMed ID: 7298596
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of the thioester bond in C3 and C4 in the determination of the conformational and functional states of the molecule.
    Isenman DE
    Ann N Y Acad Sci; 1983; 421():277-90. PubMed ID: 6202198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The thioester bond of C3.
    Levine RP; Dodds AW
    Curr Top Microbiol Immunol; 1990; 153():73-82. PubMed ID: 1688756
    [No Abstract]   [Full Text] [Related]  

  • 8. Methods to detect and quantitate complement activation.
    Cooper NR; Nemerow GR; Mayes JT
    Springer Semin Immunopathol; 1983; 6(2-3):195-212. PubMed ID: 6195745
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhibition of immune precipitation by complement.
    Hong K; Takata Y; Sayama K; Kozono H; Takeda J; Nakano Y; Kinoshita T; Inoue K
    J Immunol; 1984 Sep; 133(3):1464-70. PubMed ID: 6747294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C3, C4, and the terminal complement complex differ from C1q by binding predominantly to the antigenic part of solid phase immune complexes.
    Garred P; Michaelsen TE; Aase A; Mollnes TE
    J Immunol; 1990 Jan; 144(1):198-203. PubMed ID: 2295791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intramolecular general acid catalysis in the binding reactions of alpha 2-macroglobulin and complement components C3 and C4.
    Davies SG; Sim RB
    Biosci Rep; 1981 Jun; 1(6):461-8. PubMed ID: 6170356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Covalent binding and hemolytic activity of complement proteins.
    Law SK; Lichtenberg NA; Levine RP
    Proc Natl Acad Sci U S A; 1980 Dec; 77(12):7194-8. PubMed ID: 6938964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure and activation of the early components of complement.
    Porter RR
    Fed Proc; 1977 Aug; 36(9):2191-6. PubMed ID: 328305
    [No Abstract]   [Full Text] [Related]  

  • 14. Third component of human complement: appearance of a sulfhydryl group following chemical or enzymatic inactivation.
    Janatova J; Lorenz PE; Schechter AN; Prahl JW; Tack BF
    Biochemistry; 1980 Sep; 19(19):4471-8. PubMed ID: 7407085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C3 binds covalently to the C gamma 3 domain of IgG immune aggregates during complement activation by the alternative pathway.
    Antón LC; Alcolea JM; Sánchez-Corral P; Marqués G; Sánchez A; Vivanco F
    Biochem J; 1989 Feb; 257(3):831-8. PubMed ID: 2784671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Native conformations of human complement components C3 and C4 show different dependencies on thioester formation.
    Isaac L; Aivazian D; Taniguchi-Sidle A; Ebanks RO; Farah CS; Florido MP; Pangburn MK; Isenman DE
    Biochem J; 1998 Feb; 329 ( Pt 3)(Pt 3):705-12. PubMed ID: 9445402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C3 binds with similar efficiency to Fab and Fc regions of IgG immune aggregates.
    Antón LC; Ruiz S; Barrio E; Marqués G; Sánchez A; Vivanco F
    Eur J Immunol; 1994 Mar; 24(3):599-604. PubMed ID: 8125130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement C2 receptor inhibitor trispanning and the beta-chain of C4 share a binding site for complement C2.
    Inal JM; Schifferli JA
    J Immunol; 2002 May; 168(10):5213-21. PubMed ID: 11994478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acetohydroxamate, a urease inhibitor, inhibits the covalent binding reaction of complement proteins C3 and C4.
    Sim E; Jones A; Stanley L
    Acta Pharmacol Toxicol (Copenh); 1985 Oct; 57(4):304-6. PubMed ID: 4083040
    [No Abstract]   [Full Text] [Related]  

  • 20. The covalent binding reaction of C3 and C4.
    Law SK
    Ann N Y Acad Sci; 1983; 421():246-58. PubMed ID: 6586101
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.